Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.
Mol Oncol. 2015 Nov;9(9):1760-72. doi: 10.1016/j.molonc.2015.05.007. Epub 2015 Jun 5.
Mol Oncol. 2015.
PMID: 26119717
Free PMC article.
"Active" cancer immunotherapy by anti-Met antibody gene transfer.
Vigna E, Pacchiana G, Mazzone M, Chiriaco C, Fontani L, Basilico C, Pennacchietti S, Comoglio PM.
Vigna E, et al. Among authors: fontani l.
Cancer Res. 2008 Nov 15;68(22):9176-83. doi: 10.1158/0008-5472.CAN-08-1688.
Cancer Res. 2008.
PMID: 19010889
Item in Clipboard
Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.
Vigna E, Pacchiana G, Chiriaco C, Cignetto S, Fontani L, Michieli P, Comoglio PM.
Vigna E, et al. Among authors: fontani l.
J Mol Med (Berl). 2014 Jan;92(1):65-76. doi: 10.1007/s00109-013-1079-0. Epub 2013 Sep 7.
J Mol Med (Berl). 2014.
PMID: 24013625
Free article.
Item in Clipboard
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.
Sala V, Gallo S, Gatti S, Medico E, Vigna E, Cantarella D, Fontani L, Natale M, Cimino J, Morello M, Comoglio PM, Ponzetto A, Crepaldi T.
Sala V, et al. Among authors: fontani l.
J Mol Cell Cardiol. 2016 Apr;93:84-97. doi: 10.1016/j.yjmcc.2016.02.017. Epub 2016 Feb 26.
J Mol Cell Cardiol. 2016.
PMID: 26924269
Item in Clipboard
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.
Cignetto S, Modica C, Chiriaco C, Fontani L, Milla P, Michieli P, Comoglio PM, Vigna E.
Cignetto S, et al. Among authors: fontani l.
Mol Oncol. 2016 Jun;10(6):938-48. doi: 10.1016/j.molonc.2016.03.004. Epub 2016 Mar 28.
Mol Oncol. 2016.
PMID: 27103110
Free PMC article.
Item in Clipboard
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Chiriaco C, Donini C, Cortese M, Ughetto S, Modica C, Martinelli I, Proment A, Vitali L, Fontani L, Casucci M, Comoglio PM, Giordano S, Sangiolo D, Leuci V, Vigna E.
Chiriaco C, et al. Among authors: fontani l.
J Exp Clin Cancer Res. 2022 Oct 21;41(1):309. doi: 10.1186/s13046-022-02479-y.
J Exp Clin Cancer Res. 2022.
PMID: 36271379
Free PMC article.
Item in Clipboard
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.
D'Amico L, Patanè S, Grange C, Bussolati B, Isella C, Fontani L, Godio L, Cilli M, D'Amelio P, Isaia G, Medico E, Ferracini R, Roato I.
D'Amico L, et al. Among authors: fontani l.
Br J Cancer. 2013 Jun 25;108(12):2525-36. doi: 10.1038/bjc.2013.271.
Br J Cancer. 2013.
PMID: 23801032
Free PMC article.
Item in Clipboard
[Neuropsychological aspects of schizophrenic mental deterioration].
Roccatagliata G, Arcuri T, Ivaldi M, Fontani L, Maffini M, Cocito L.
Roccatagliata G, et al. Among authors: fontani l.
Riv Neurol. 1979 Nov-Dec;49(6):440-50.
Riv Neurol. 1979.
PMID: 549213
Italian.
Item in Clipboard
Cite
Cite